Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples